Centre for Obesity Research and Education (CORE), The Alfred Centre, The Alfred Hospital, Monash University, Level 6, 99 Commercial Road, Melbourne, Victoria, 3004, Australia.
Obes Surg. 2012 Nov;22(11):1666-75. doi: 10.1007/s11695-012-0682-4.
The Beck Depression Inventory (BDI) is one of the most commonly used instruments to assess depression in persons with obesity. While it has been validated in normal and psychiatric populations, in obese populations, its validity remains uncertain. This study aimed to investigate the validity and reliability of the BDI-IA and BDI-II in severely obese bariatric surgery candidates.
Consecutive new candidates at a bariatric surgery clinic were invited to participate in the study by their consulting surgeon. All candidates were assessed using the Structured Clinical Interview for DSM-IV Disorders (SCID-I); 118 completed the BDI-IA and 83 completed the BDI-II. Two hundred one patients (response rate, 88 %) participated in the study. The current sample (82 % female) had an average body mass index of 42.83 ± 6.34 and an average age of 45 ± 12 years.
Based on the SCID-I, 54 candidates (26.9 %) met the criteria for a mood disorder, with 37 meeting the criteria for current major depressive disorder. Individuals diagnosed with a clinical mood disorder had significantly higher scores on the BDI (BDI-IA, 23.59 ± 9.69 vs. 12.76 ± 8.29; BDI-II, 22.93 ± 5.22 vs. 11.25 ± 8.44). Our results indicated that, as a screening tool for a clinical mood disorder, the BDI-II had an optimal cutoff of 13, with a sensitivity of 100 and specificity of 67.75.
Results indicated that the BDI-IA should not be used as a tool to measure depressive symptomatology in obese bariatric surgery candidates. No cutoff was identified with adequate sensitivity and specificity, and over 20 % of patients were misclassified. As a screening tool for a clinical mood disorder, the BDI-II was adequate; however, prevalence rates were significantly overestimated.
贝克抑郁自评量表(BDI)是评估肥胖人群抑郁症状最常用的工具之一。虽然它已经在正常人群和精神科人群中得到验证,但在肥胖人群中,其有效性仍不确定。本研究旨在调查 BDI-IA 和 BDI-II 在严重肥胖症患者中的有效性和可靠性。
肥胖症手术门诊的连续新候选者被他们的顾问外科医生邀请参加研究。所有候选者均使用 DSM-IV 障碍定式临床访谈(SCID-I)进行评估;118 人完成了 BDI-IA,83 人完成了 BDI-II。共有 201 名患者(应答率 88%)参与了研究。当前样本(82%为女性)的平均体重指数为 42.83±6.34,平均年龄为 45±12 岁。
根据 SCID-I,54 名候选者(26.9%)符合心境障碍标准,其中 37 名符合当前重度抑郁症标准。被诊断为临床心境障碍的个体在 BDI 上的得分明显更高(BDI-IA,23.59±9.69 vs. 12.76±8.29;BDI-II,22.93±5.22 vs. 11.25±8.44)。我们的结果表明,作为临床心境障碍的筛查工具,BDI-II 的最佳截断值为 13,其敏感性为 100%,特异性为 67.75%。
结果表明,BDI-IA 不应用于测量肥胖症手术候选者的抑郁症状。没有确定具有足够敏感性和特异性的截断值,超过 20%的患者被错误分类。作为临床心境障碍的筛查工具,BDI-II 是足够的;然而,患病率被显著高估。